Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Brain Metastasis, HER2+ Breast Cancer

Nancy Lin

MD

🏢Dana-Farber Cancer Institute🌐USA

Associate Chief, Division of Breast Oncology

55
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Nancy Lin is a leading expert on HER2-positive breast cancer with a particular focus on CNS metastases. She led key analyses of tucatinib in HER2CLIMB demonstrating CNS activity and contributed to the evaluation of trastuzumab deruxtecan for brain metastases. Her work has transformed the management of HER2+ breast cancer brain metastases by establishing targeted systemic therapies as effective CNS-active options.

Share:

🧪Research Fields 研究领域

HER2-positive breast cancer brain metastases
tucatinib HER2 CNS
trastuzumab deruxtecan CNS activity
leptomeningeal disease breast cancer
CNS-active HER2 therapies

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Nancy Lin 的研究动态

Follow Nancy Lin's research updates

留下邮箱,当我们发布与 Nancy Lin(Dana-Farber Cancer Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment